What are the best treatments for Weaver Syndrome?

Weaver Syndrome is a rare overgrowth disorder characterized by accelerated skeletal maturation and distinct craniofacial features, for which there is currently no single curative treatment. Management is focused on addressing specific clinical symptoms through a multidisciplinary approach, including physical and occupational therapy, orthopedic monitoring, and developmental support.

What are the primary treatment strategies for Weaver Syndrome?

Because Weaver Syndrome is caused by pathogenic variants in the EZH2 gene, clinical management is strictly supportive rather than curative. There is no medication to reverse the underlying genetic overgrowth. Instead, treatment focuses on maximizing functional outcomes and managing complications. Effectiveness varies significantly between individuals, as the severity of the phenotype—particularly the degree of macrocephaly and skeletal advancement—differs from case to case.

Which therapies help manage Weaver Syndrome symptoms?

Non-pharmacological interventions are the cornerstone of care for patients with Weaver Syndrome. A structured care plan typically includes:

• Physical Therapy: Essential for addressing hypotonia and improving motor coordination.


• Occupational Therapy: Useful for refining fine motor skills and supporting activities of daily living.


• Speech Therapy: Often required to address potential delays in speech development or feeding difficulties.


• Orthopedic Interventions: Regular monitoring for scoliosis or foot deformities, which may require bracing or, in rare cases, surgical correction.

Which specialists should be on the care team?

Due to the multisystem nature of Weaver Syndrome, a coordinated multidisciplinary team is essential. We recommend assembling a team that includes a clinical geneticist, a pediatrician, an orthopedist, a physical therapist, and a neurologist if seizures or developmental delays are present. At DiseaseMaps.org, we have seen 6 members share their experiences with Weaver Syndrome, highlighting the value of peer support alongside clinical oversight.

Are there emerging treatments for Weaver Syndrome?

Currently, there are no specific clinical trials targeting the underlying mechanism of Weaver Syndrome. Research remains focused on better characterizing the EZH2 gene function to improve diagnostic accuracy and long-term prognosis. Patients and families are encouraged to monitor clinical trial databases for emerging studies related to overgrowth syndromes.

Next steps

• Consult with a clinical geneticist to confirm the Weaver Syndrome diagnosis via molecular testing.


• Establish a long-term follow-up schedule with a pediatric orthopedic specialist.


• Connect with the DiseaseMaps.org community to share experiences with other families affected by Weaver Syndrome.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; all treatment decisions must be personalized by your healthcare team.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Weaver Syndrome Overview.


• Orphanet: Rare Disease Database (ORPHA:900).


• OMIM (Online Mendelian Inheritance in Man): #277590 Weaver Syndrome.